Global Macular Edema Therapeutics Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 103

Report ID: 3488

Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME).
The market of macular edema is dominated by North America which is followed by Europe due tremendous number of population suffering from diabetics. Asia Pacific region have also shown faster rate of increases of macular edema therapeutics market. While Africa and Australia have low market of Macular edema. In Asia pacific region India, China and Brazil have shown emerging growth in the global market of macular edema therapeutics.
In 2018, the global Macular Edema Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Macular Edema Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Macular Edema Therapeutics development in United States, Europe and China.

The key players covered in this study
Allergan
Novartis
Roche
Regeneron Pharmaceuticals
Pfizer
Bayer
Boehringer Ingelheim
Bausch & Lomb
Aciont
ActiveSite Pharmaceuticals
Adverum Biotechnologies
Aerpio Therapeutics
Ampio Pharmaceuticals
Araim Pharmaceuticals
Astellas Pharma

Market segment by Type, the product can be split into
Laser Treatment
Anti-VEGF Injection
Anti-Inflammatory Treatment
Vitrectomy

Market segment by Application, split into
Cystoid Macular Edema (CME)
Diabetic Macular Edema(DME)

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Macular Edema Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Macular Edema Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Macular Edema Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Macular Edema Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Laser Treatment
1.4.3 Anti-VEGF Injection
1.4.4 Anti-Inflammatory Treatment
1.4.5 Vitrectomy
1.5 Market by Application
1.5.1 Global Macular Edema Therapeutics Market Share by Application (2014-2025)
1.5.2 Cystoid Macular Edema (CME)
1.5.3 Diabetic Macular Edema(DME)
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Macular Edema Therapeutics Market Size
2.2 Macular Edema Therapeutics Growth Trends by Regions
2.2.1 Macular Edema Therapeutics Market Size by Regions (2014-2025)
2.2.2 Macular Edema Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Macular Edema Therapeutics Market Size by Manufacturers
3.1.1 Global Macular Edema Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Macular Edema Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Macular Edema Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Macular Edema Therapeutics Key Players Head office and Area Served
3.3 Key Players Macular Edema Therapeutics Product/Solution/Service
3.4 Date of Enter into Macular Edema Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Macular Edema Therapeutics Market Size by Type (2014-2019)
4.2 Global Macular Edema Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Macular Edema Therapeutics Market Size (2014-2019)
5.2 Macular Edema Therapeutics Key Players in United States
5.3 United States Macular Edema Therapeutics Market Size by Type
5.4 United States Macular Edema Therapeutics Market Size by Application

6 Europe
6.1 Europe Macular Edema Therapeutics Market Size (2014-2019)
6.2 Macular Edema Therapeutics Key Players in Europe
6.3 Europe Macular Edema Therapeutics Market Size by Type
6.4 Europe Macular Edema Therapeutics Market Size by Application

7 China
7.1 China Macular Edema Therapeutics Market Size (2014-2019)
7.2 Macular Edema Therapeutics Key Players in China
7.3 China Macular Edema Therapeutics Market Size by Type
7.4 China Macular Edema Therapeutics Market Size by Application

8 Japan
8.1 Japan Macular Edema Therapeutics Market Size (2014-2019)
8.2 Macular Edema Therapeutics Key Players in Japan
8.3 Japan Macular Edema Therapeutics Market Size by Type
8.4 Japan Macular Edema Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Macular Edema Therapeutics Market Size (2014-2019)
9.2 Macular Edema Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Macular Edema Therapeutics Market Size by Type
9.4 Southeast Asia Macular Edema Therapeutics Market Size by Application

10 India
10.1 India Macular Edema Therapeutics Market Size (2014-2019)
10.2 Macular Edema Therapeutics Key Players in India
10.3 India Macular Edema Therapeutics Market Size by Type
10.4 India Macular Edema Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Macular Edema Therapeutics Market Size (2014-2019)
11.2 Macular Edema Therapeutics Key Players in Central & South America
11.3 Central & South America Macular Edema Therapeutics Market Size by Type
11.4 Central & South America Macular Edema Therapeutics Market Size by Application

12 International Players Profiles
12.1 Allergan
12.1.1 Allergan Company Details
12.1.2 Company Description and Business Overview
12.1.3 Macular Edema Therapeutics Introduction
12.1.4 Allergan Revenue in Macular Edema Therapeutics Business (2014-2019)
12.1.5 Allergan Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Macular Edema Therapeutics Introduction
12.2.4 Novartis Revenue in Macular Edema Therapeutics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Macular Edema Therapeutics Introduction
12.3.4 Roche Revenue in Macular Edema Therapeutics Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Regeneron Pharmaceuticals
12.4.1 Regeneron Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Macular Edema Therapeutics Introduction
12.4.4 Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2014-2019)
12.4.5 Regeneron Pharmaceuticals Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Macular Edema Therapeutics Introduction
12.5.4 Pfizer Revenue in Macular Edema Therapeutics Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Macular Edema Therapeutics Introduction
12.6.4 Bayer Revenue in Macular Edema Therapeutics Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Boehringer Ingelheim
12.7.1 Boehringer Ingelheim Company Details
12.7.2 Company Description and Business Overview
12.7.3 Macular Edema Therapeutics Introduction
12.7.4 Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2014-2019)
12.7.5 Boehringer Ingelheim Recent Development
12.8 Bausch & Lomb
12.8.1 Bausch & Lomb Company Details
12.8.2 Company Description and Business Overview
12.8.3 Macular Edema Therapeutics Introduction
12.8.4 Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2014-2019)
12.8.5 Bausch & Lomb Recent Development
12.9 Aciont
12.9.1 Aciont Company Details
12.9.2 Company Description and Business Overview
12.9.3 Macular Edema Therapeutics Introduction
12.9.4 Aciont Revenue in Macular Edema Therapeutics Business (2014-2019)
12.9.5 Aciont Recent Development
12.10 ActiveSite Pharmaceuticals
12.10.1 ActiveSite Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Macular Edema Therapeutics Introduction
12.10.4 ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2014-2019)
12.10.5 ActiveSite Pharmaceuticals Recent Development
12.11 Adverum Biotechnologies
12.12 Aerpio Therapeutics
12.13 Ampio Pharmaceuticals
12.14 Araim Pharmaceuticals
12.15 Astellas Pharma

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details